48 Sessions  PREVNEXT

  • Main Hall
    1F
  • Sakura
    1F
  • Annex 1
    1F
  • Annex 2
    1F
  • Room A
    2F
  • Room B1
    2F
  • Room B2
    2F
  • Room C2
    1F
  • Room D
    1F
  • Room E
    1F
8:00 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00 21:00 22:00

11:15

ShinyaYamanaka{YAMANAKASHINYA}____Plenary Lecture 1
Recent Progress in iPS Cell Research and Application|1|2|AkinoriAkaike{AKAIKEAKINORI}____

S02

Plenary Lecture 1
Recent Progress in i...

08:30

MakotoHiguchi{HIGUCHIMAKOTO}____Cutting Edge Lecture 1
Molecular imaging for diagnosis and treatment of neurodegenerative disorders at a prodromal stage|1|3|MasahiroNomoto{NOMOTOMASAHIRO}____

S09

Cutting Edge Lecture 1
Molec...

08:30

BaofengYang{YANGBAOFENG}____Cutting Edge Lecture 2
The role of non-coding RNAs in malignant cardiac diseases|1|4|KyoichiOhashi{OHASHIKYOICHI}____

S10

Cutting Edge Lecture 2
The r...

08:30

StephenB.Mcmahon{MCMAHONSTEPHENB.}____Cutting Edge Lecture 3
Large scale optical imaging of peripheral and central nociceptive pathways in vivo|1|5|HiroshiUeda{UEDAHIROSHI}____

S11

Cutting Edge Lecture 3
Large...

08:30

TatsuyaKondo{KONDOTATSUYA}____Cutting Edge Lecture 4
PMDA's Initiatives Based on Regulatory Science. In Pursuit of Developing Innovative Drugs and Medical Devices|1|6|HideoKusuoka{KUSUOKAHIDEO}____

S12

Cutting Edge Lecture 4
PMDA'...

08:30

JensTitze{TITZEJENS}____Cutting Edge Lecture 5
Rethinking Sodium Metabolism|1|7|AkiraNishiyama{NISHIYAMAAKIRA}____

S13

Cutting Edge Lecture 5
Rethi...

15:05

ShunyaIkeda{IKEDASHUNYA}____Cutting Edge Lecture 6
Cost-effectiveness Analysis for Health Policy Making in Japan|1|8|TsutomuYamazaki{YAMAZAKITSUTOMU}____

S14

Cutting Edge Lecture 6
Cost-...

08:30

ChikashiToyoshima{TOYOSHIMACHIKASHI}____Cutting Edge Lecture 7
Structural biology of the calcium pump|1|9|ToyoakiMurohara{MUROHARATOYOAKI}____

S15

Cutting Edge Lecture 7
Struc...

08:30

GarretA.FitzGerald{FITZGERALDGARRETA.}____Cutting Edge Lecture 8
Systems Pharmacology and Translational Therapeutics|Astellas Pharma Inc.|1|10|HitoshiOkamura{OKAMURAHITOSHI}____

S16

Cutting Edge Lecture 8
Syste...

Sponsor:Astellas Pharma Inc.

08:30

RonaldS.Duman{DUMANRONALDS.}____Cutting Edge Lecture 9
Neurobiology of Stress, Depression, and Antidepressants: Remodeling Synaptic Connections|1|3|TomoyukiFuruyashiki{FURUYASHIKITOMOYUKI}____

S17

Cutting Edge Lecture 9
Neuro...

13:50

MasatoshiHagiwara{HAGIWARAMASATOSHI}____The 11th Ebashi Setsuro Award Lecture
The Impossible Dream Comes True: Magic Bullets Targeting Incurable Diseases|1|1|HiroshiIwao{IWAOHIROSHI}____

S42

The 11th Ebashi Setsuro Award Lecture...

14:50

YasuhikoIzumi{IZUMIYASUHIKO}|MuneyoshiOkada{OKADAMUNEYOSHI}|TakahiroShimizu{SHIMIZUTAKAHIRO}____JPS/The 33rd Encouragement of Young Investigator Award Lectures |1|1|KumikoIshige{ISHIGEKUMIKO}____

S43

JPS/The 33rd Encouragement of Young Investigator Award Lectures

09:25

TakeshiIwatsubo{IWATSUBOTAKESHI}|ColinL.Masters{MASTERSCOLINL.}|MolinuevoJoséLuis{MOLINUEVOJOSÉLUIS}|MichaelD.Devous{DEVOUSMICHAELD.}____Symposium 1
Alzheimer's disease; Toward very early diagnosis and treatment|1|3|TakeshiIwatsubo{IWATSUBOTAKESHI}|ColinL.Masters{MASTERSCOLINL.}____

S45

Symposium 1
Alzheimer's disease; Toward very early diagnosis and...

16:10

HaruhikoBito{BITOHARUHIKO}|AdamE.Cohen{COHENADAME.}|VivianaGradinaru{GRADINARUVIVIANA}____Symposium 2
Transformative technologies at the forefront of brain research|1|3|HaruhikoBito{BITOHARUHIKO}|VivianaGradinaru{GRADINARUVIVIANA}____MasatoshiInoue{INOUEMASATOSHI}|MasayukiSakamoto{SAKAMOTOMASAYUKI}|HajimeFujii{FUJIIHAJIME}|YoavAdam{ADAMYOAV}|HongkangZhang{ZHANGHONGKANG}

S46

Symposium 2
Transformative technologies at the forefront of brai...

09:25

SandoshPadmanabhan{PADMANABHANSANDOSH}|NeerajDhaun(Bean){DHAUN(BEAN)NEERAJ}|UnaMartin{MARTINUNA}|DavidJ.Webb{WEBBDAVIDJ.}____Symposium 3
Hypertension: New developments in understanding and management|1|4|DavidJ.Webb{WEBBDAVIDJ.}|HiroshiWatanabe{WATANABEHIROSHI}____

S47

Symposium 3
Hypertension: New developments in understanding and ...

16:10

KennethWalsh{WALSHKENNETH}|JunichiSadoshima{SADOSHIMAJUNICHI}|MotohiroNishida{NISHIDAMOTOHIRO}|KaiC.Wollert{WOLLERTKAIC.}____Symposium 4
Recent advances in the molecular and cellular understanding of heart failure-Toward novel therapeutic strategies|1|4|YasushiFujio{FUJIOYASUSHI}|KaiC.Wollert{WOLLERTKAIC.}____ToshiroSaito{SAITOTOSHIRO}|TakuroNumaga-Tomita{NUMAGA-TOMITATAKURO}|KazuhiroNishiyama{NISHIYAMAKAZUHIRO}|TomohiroTanaka{TANAKATOMOHIRO}|AkiyukiNishimura{NISHIMURAAKIYUKI}

S48

Symposium 4
Recent advances in the molecular and cellular unders...

09:25

ThomasVoets{VOETSTHOMAS}|ReinholdPenner{PENNERREINHOLD}|ShujiKaneko{KANEKOSHUJI}____Symposium 5
Pain Sensor|1|5|YasuoMori{MORIYASUO}|ThomasVoets{VOETSTHOMAS}____TakayukiNakagawa{NAKAGAWATAKAYUKI}

S49

Symposium 5
Pain Sensor

16:10

AndreasZimmer{ZIMMERANDREAS}|HiroshiUeda{UEDAHIROSHI}|MinoruNarita{NARITAMINORU}____Symposium 6
Central Pain and Translation|1|5|HiroshiUeda{UEDAHIROSHI}|GeraldW.Zamponi{ZAMPONIGERALDW.}____

S50

Symposium 6
Central Pain and Translation

09:25

ShinichiroUeda{UEDASHINICHIRO}|SimonMaxwell{MAXWELLSIMON}|YlvaBöttiger{BÖTTIGERYLVA}____Symposium 7
European & Asian training initiatives to improve safe and effective use of medicines in modern healthcare|1|11|NaokiMatsumoto{MATSUMOTONAOKI}|SimonMaxwell{MAXWELLSIMON}____

S51

Symposium 7
European & Asian training initiatives to improve saf...

14:00

KenArai{ARAIKEN}|AnnaRosell{ROSELLANNA}|Yoon-KyungChoi{CHOIYOON-KYUNG}|HisashiShirakawa{SHIRAKAWAHISASHI}____Symposium 8
Mechanisms of white matter damage and repair: New therapeutic approaches for CNS diseases|1|1|KenArai{ARAIKEN}|HisashiShirakawa{SHIRAKAWAHISASHI}____TakakuniMaki{MAKITAKAKUNI}|AnnaMorancho{MORANCHOANNA}|KazuhideHayakawa{HAYAKAWAKAZUHIDE}|AlbaGrayston{GRAYSTONALBA}|JoanMontaner{MONTANERJOAN}|EngHLo{LOENGH}|KenArai{ARAIKEN}|YongHeeKim{KIMYONGHEE}|SeungHeeKim{KIMSEUNGHEE}|HuiJuLee{LEEHUIJU}|EunyoungJung{JUNGEUNYOUNG}

S52

Symposium 8
Mechanisms of white matter damage and repair: New th...

16:10

SimonMaxwell{MAXWELLSIMON}|JohnL.Szarek{SZAREKJOHNL.}|LeszekWojnowski{WOJNOWSKILESZEK}|ElizabethA.Davis{DAVISELIZABETHA.}|Chay-HoonTan{TANCHAY-HOON}____Symposium 9
Introducing the IUPHAR Pharmacology Education Project - www.pharmacologyeducation.org|1|11|JohnL.Szarek{SZAREKJOHNL.}|SimonMaxwell{MAXWELLSIMON}____DativaTibyampansha{TIBYAMPANSHADATIVA}|DanielSchuetz{SCHUETZDANIEL}

S53

Symposium 9
Introducing the IUPHAR Pharmacology Education Projec...

09:25

DominikN.Müller{MÜLLERDOMINIKN.}|JihwanPark{PARKJIHWAN}|DaisukeNakano{NAKANODAISUKE}|KenjiOsafune{OSAFUNEKENJI}____Symposium 10
New pharmacological approaches for renal diseases|1|7|JanDanser{DANSERJAN}|AkiraNishiyama{NISHIYAMAAKIRA}____RojeshShrestha{SHRESTHAROJESH}|ChengxiangQiu{QIUCHENGXIANG}|AyanoKondo{KONDOAYANO}|ShizhengHuang{HUANGSHIZHENG}|MaxWerth{WERTHMAX}|MingyaoLi{LIMINGYAO}|JonathanBarasch{BARASCHJONATHAN}|SusztákKatalin{SUSZTÁKKATALIN}

S54

Symposium 10
New pharmacological approaches for renal diseases

16:10

DavidJ.Webb{WEBBDAVIDJ.}|KarenSamuels{SAMUELSKAREN}|DyfrigA.Hughes{HUGHESDYFRIGA.}|KenPaterson{PATERSONKEN}____Symposium 11
Health Technology Assessment (HTA) for Smaller Countries: The central role of clinical pharmacology|1|8|PhilipA.Routledge{ROUTLEDGEPHILIPA.}|DavidJ.Webb{WEBBDAVIDJ.}____

S55

Symposium 11
Health Technology Assessment (HTA) for Smaller Coun...

13:50

JohnN.vandenAnker{VANDENANKERJOHNN.}|KarelAllegaert{ALLEGAERTKAREL}|WeiZhao{ZHAOWEI}|NatellaRakhmanina{RAKHMANINANATELLA}____Symposium 12
Perinatal Pharmacology|1|12|KarelAllegaert{ALLEGAERTKAREL}|JohnN.vandenAnker{VANDENANKERJOHNN.}____

S56

Symposium 12
Perinatal Pharmacology

16:10

ShunichiTakahashi{TAKAHASHISHUNICHI}|YoshinoriIkeura{IKEURAYOSHINORI}|KevinGrimes{GRIMESKEVIN}____Symposium 13
Open Innovation for Drug Discovery|1|13|AshleyJ.Stevens{STEVENSASHLEYJ.}|ChikakoSaotome{SAOTOMECHIKAKO}____

S57

Symposium 13
Open Innovation for Drug Discovery

09:25

ThomasGrutter{GRUTTERTHOMAS}|CyrilGoudet{GOUDETCYRIL}|RyoichiroKageyama{KAGEYAMARYOICHIRO}|HaruoKasai{KASAIHARUO}____Symposium 14
Photobiology: Understanding of biological systems by illuminating and controlling biological functions by light|1|10|RyoichiroKageyama{KAGEYAMARYOICHIRO}|CyrilGoudet{GOUDETCYRIL}____MakikoNegishi{NEGISHIMAKIKO}

S58

Symposium 14
Photobiology: Understanding of biological systems b...

16:10

MasayukiYamamoto{YAMAMOTOMASAYUKI}|ThomasW.Kensler{KENSLERTHOMASW.}|JingboPi{PIJINGBO}|KenItoh{ITOHKEN}____Symposium 15
Targeting antioxidant defence system in redox diseases|1|10|Mi-KyoungKwak{KWAKMI-KYOUNG}|ThomasW.Kensler{KENSLERTHOMASW.}____JohnDGroopman{GROOPMANJOHND}|KeikoTaguchi{TAGUCHIKEIKO}|MasayukiYamamoto{YAMAMOTOMASAYUKI}|JingqiFu{FUJINGQI}|HongzhiZheng{ZHENGHONGZHI}|QiCui{CUIQI}|ChengjieChen{CHENCHENGJIE}|HuihuiWang{WANGHUIHUI}|YongyongHou{HOUYONGYONG}|YuanyuanXu{XUYUANYUAN}

S59

Symposium 15
Targeting antioxidant defence system in redox diseases

09:25

IchioShimada{SHIMADAICHIO}|YoshinoriFujiyoshi{FUJIYOSHIYOSHINORI}|YifanCheng{CHENGYIFAN}____Symposium 16
Drug design based on 3D microstructure of receptors|1|3|YifanCheng{CHENGYIFAN}|YujiIkegaya{IKEGAYAYUJI}____

S60

Symposium 16
Drug design based on 3D microstructure of receptors

13:50

Marie-EveTremblay{TREMBLAYMARIE-EVE}|CJustinLee{LEECJUSTIN}|ShuminDuan{DUANSHUMIN}|SchuichiKoizumi{KOIZUMISCHUICHI}____Symposium 17
Glia-targeted Therapies: New Technical Advances for Seeing and Manipulating Glial Functions in the Brain Diseases|1|3|SchuichiKoizumi{KOIZUMISCHUICHI}|Marie-EveTremblay{TREMBLAYMARIE-EVE}____

S61

Symposium 17
Glia-targeted Therapies: New Technical Advances for...

16:10

KouichiYoshimasu{YOSHIMASUKOUICHI}|AntoniRamos-Quiroga{RAMOS-QUIROGAANTONI}|WimvandenBrink{VANDENBRINKWIM}|Pieter-JanCarpentier{CARPENTIERPIETER-JAN}____Symposium 18
ADHD and Substance Use Disorders: Epidemiology, neurobiology and treatment|1|3|WimvandenBrink{VANDENBRINKWIM}|TamarWohlfarth{WOHLFARTHTAMAR}____

S62

Symposium 18
ADHD and Substance Use Disorders: Epidemiology, neu...

12:30

HirokiR.Ueda{UEDAHIROKIR.}____JPS Frontiers Session 1
Towards Organism-level Systems Biology|1|1|HitoshiHashimoto{HASHIMOTOHITOSHI}____

K3

JPS Frontiers Session 1
Towards Organi...

12:30

AtsushiYonezawa{YONEZAWAATSUSHI}____JSCPT Frontiers Session 1
Pharmacokinetics and Pharmacodynamics of Therapeutic Monoclonal Antibodies for Personalized Medicine|1|1|YuichiAndo{ANDOYUICHI}____

K6

JSCPT Frontiers Session 1
Pharmacokine...

12:30

AnnetteGross{GROSSANNETTE}|OscarDellaPasqua{PASQUAOSCARDELLA}____Luncheon Seminar 1
The challenges of understanding interindividual variability in the era of ICH E17: From qualitative to quantitative approaches in the development of medicines|GlaxoSmithKline K.K.|1|1|KihitoTakahashi{TAKAHASHIKIHITO}____

LS1

Luncheon Seminar 1
The challenges of u...

Sponsor:GlaxoSmithKline K.K.

12:30

KojiTamada{TAMADAKOJI}____Luncheon Seminar 2
Recent advances and future perspective of cancer immunotherapy|ONO PHARMACEUTICAL CO., LTD.|1|1|MasatakaMajima{MAJIMAMASATAKA}____

LS2

Luncheon Seminar 2
Recent advances and...

Sponsor:ONO PHARMACEUTICAL CO., LTD.

12:30

-____JSCPT Session (Japanese)|AYUMI Pharmaceutical Corporation|1|1|-____

LS3

JSCPT Session (Japanese)

Sponsor:AYUMI Pharmaceutical Corporation

12:30

ToshioFujimoto{FUJIMOTOTOSHIO}____Luncheon Seminar 4
Creating Open Innovation ecosystem in Shonan iPark|Takeda Pharmaceutical Company Limited|1|1|YoshinoriIkeura{IKEURAYOSHINORI}____

LS4

Luncheon Seminar 4
Creating Open Innov...

Sponsor:Takeda Pharmaceutical Company Limited

18:10

ShuNarumiya{NARUMIYASHU}|Yiu-LianFong{FONGYIU-LIAN}|-|JoanHellerBrown{BROWNJOANHELLER}|AngelaHaczku{HACZKUANGELA}|ChihiroYabe-Nishimura{YABE-NISHIMURACHIHIRO}|RiekoMuramatsu{MURAMATSURIEKO}|KenjiNonaka{NONAKAKENJI}____Johnson & Johnson: Janssen Evening Seminar|Johnson & Johnson K.K. Janssen Pharmaceutical K.K.|1|1|Yiu-LianFong{FONGYIU-LIAN}____

ES

Johnson & Johnson: Janssen Evening Seminar

Sponsor:Johnson & Johnson K.K. Janssen Pharmaceutical K.K.

13:50

KosukeOtani{OTANIKOSUKE}|KengoMatsumoto{MATSUMOTOKENGO}|MingyuHuo{HUOMINGYU}|BarbaraKKemp-Harper{KEMP-HARPERBARBARAK}|FranciscoPerez-Vizcaino{PEREZ-VIZCAINOFRANCISCO}____Oral session 1
Cardiovascular System 1: Hypertension/Pulmonary Hypertension|1|1|YoshihiroFukumoto{FUKUMOTOYOSHIHIRO}|A.H.JDanser{DANSERA.H.J}____MuneyoshiOkada{OKADAMUNEYOSHI}|HideyukiYamawaki{YAMAWAKIHIDEYUKI}|SatoshiKameshima{KAMESHIMASATOSHI}|KikoHori{HORIKIKO}|HongsongZhang{ZHANGHONGSONG}|DanyangTian{TIANDANYANG}|ChiWaiLau{LAUCHIWAI}|YalanWu{WUYALAN}|AjayChawla{CHAWLAAJAY}|YuHuang{HUANGYU}|XiaoYuTian{TIANXIAOYU}|CaitlinVLewis{LEWISCAITLINV}|MayZhu{ZHUMAY}|MaggieLieu{LIEUMAGGIE}|SeyuriMoodley{MOODLEYSEYURI}|YanWang{WANGYAN}|RobertEWiddop{WIDDOPROBERTE}|ChrishanSSamuel{SAMUELCHRISHANS}|GrantRDrummond{DRUMMONDGRANTR}|MariaCallejo{CALLEJOMARIA}|GemaMondejar-Parreno{MONDEJAR-PARRENOGEMA}|DanielMorales-Cano{MORALES-CANODANIEL}|BiancaBarreira{BARREIRABIANCA}|SergioEsquivel-Ruiz{ESQUIVEL-RUIZSERGIO}|EscribanoPilar{PILARESCRIBANO}|LauraMoreno{MORENOLAURA}|JoanABarbera{BARBERAJOANA}|AngelCogolludo{COGOLLUDOANGEL}

O1

Oral session 1
Cardiovascular System 1...

14:50

TakahisaMatsuda{MATSUDATAKAHISA}|YumaHorii{HORIIYUMA}|KotaroMatsumoto{MATSUMOTOKOTARO}|AtsuhikoT.Naito{NAITOATSUHIKOT.}|GiseleZapata-Sudo{ZAPATA-SUDOGISELE}____Oral session 2
Cardiovascular System 2: Heart/Ischemia-reperfusion|1|1|YoshioGoshima{GOSHIMAYOSHIO}|KennethWalsh{WALSHKENNETH}____PeiyongZhai{ZHAIPEIYONG}|SebastianoSciarretta{SCIARRETTASEBASTIANO}|YuZhang{ZHANGYU}|JaeImJeong{JEONGJAEIM}|ShoheiIkeda{IKEDASHOHEI}|JiyeonPark{PARKJIYEON}|Chiao-PoHsu{HSUCHIAO-PO}|BinTian{TIANBIN}|DuojiaPan{PANDUOJIA}|JunichiSadoshima{SADOSHIMAJUNICHI}|DominicPDelRe{DELREDOMINICP}|MichioNakaya{NAKAYAMICHIO}|HiroakiNishihara{NISHIHARAHIROAKI}|HirokiOhara{OHARAHIROKI}|KenjiWatari{WATARIKENJI}|AkiomiNagasaka{NAGASAKAAKIOMI}|HitoshiKurose{KUROSEHITOSHI}|MasanoriObana{OBANAMASANORI}|MakikoMaeda{MAEDAMAKIKO}|HiroyukiNakayama{NAKAYAMAHIROYUKI}|YasushiFujio{FUJIOYASUSHI}|TomoakiHigo{HIGOTOMOAKI}|HirokoIzumi-Nakaseko{IZUMI-NAKASEKOHIROKO}|KentaroAndo{ANDOKENTARO}|MihokoHagiwara-Nagasawa{HAGIWARA-NAGASAWAMIHOKO}|YujiNakamura{NAKAMURAYUJI}|AtsushiSugiyama{SUGIYAMAATSUSHI}|JaquelineS.DaSilva{DASILVAJAQUELINES.}|FabricioBeltrame{BELTRAMEFABRICIO}|TadeuL.Montagnoli{MONTAGNOLITADEUL.}|LeticiaM.Barbosa{BARBOSALETICIAM.}|LuizaV.Mendes{MENDESLUIZAV.}|ValeriaM.Cunha{CUNHAVALERIAM.}|RodolfoC.Maia{MAIARODOLFOC.}|CarlosA.Fraga{FRAGACARLOSA.}|RobertoT.Sudo{SUDOROBERTOT.}

O2

Oral session 2
Cardiovascular System 2...

13:50

DebbieLHay{HAYDEBBIEL}|RisaDomoto{DOMOTORISA}|NathalieVergnolle{VERGNOLLENATHALIE}|NorikazuKiguchi{KIGUCHINORIKAZU}|RobertoT.Sudo{SUDOROBERTOT.}____Oral session 3
Pain|1|1|NathalieVergnolle{VERGNOLLENATHALIE}|MakotoTsuda{TSUDAMAKOTO}____AqfanJamaluddin{JAMALUDDINAQFAN}|ElyseWilliams{WILLIAMSELYSE}|MargaretBrimble{BRIMBLEMARGARET}|PaulHarris{HARRISPAUL}|ChristopherWalker{WALKERCHRISTOPHER}|KerryLoomes{LOOMESKERRY}|DaichiYamasoba{YAMASOBADAICHI}|HirokiYamanishi{YAMANISHIHIROKI}|FumikoSekiguchi{SEKIGUCHIFUMIKO}|MahoTsubota{TSUBOTAMAHO}|MasahiroNishibori{NISHIBORIMASAHIRO}|AtsufumiKawabata{KAWABATAATSUFUMI}|CleoDesormeaux{DESORMEAUXCLEO}|TeresaBautsova{BAUTSOVATERESA}|CorinneRolland{ROLLANDCORINNE}|GiovanniBarbara{BARBARAGIOVANNI}|StuartBrierley{BRIERLEYSTUART}|NicolasCenac{CENACNICOLAS}|FumihiroSaika{SAIKAFUMIHIRO}|DaichiKobayashi{KOBAYASHIDAICHI}|ShinsukeMatsuzaki{MATSUZAKISHINSUKE}|ShirohKishioka{KISHIOKASHIROH}|GuilhermeC.Montes{MONTESGUILHERMEC.}|BismarckRezende{REZENDEBISMARCK}|RodolfoC.Maia{MAIARODOLFOC.}|TadeuL.Montagnoli{MONTAGNOLITADEUL.}|CarlosA.Fraga{FRAGACARLOSA.}|EliezerJ.Barreiro{BARREIROELIEZERJ.}|GiseleZapata-Sudo{ZAPATA-SUDOGISELE}

O3

Oral session 3
Pain

13:50

MariaHJaentti{JAENTTIMARIAH}|DylanTMarsh{MARSHDYLANT}|MichaM.M.Wilhelmus{WILHELMUSMICHAM.M.}|KazuyukiTakata{TAKATAKAZUYUKI}|IshumeetKaurBajwa{BAJWAISHUMEETKAUR}____Oral session 4
Neuroscience 1: Dementia|1|1|ScottSmid{SMIDSCOTT}|KazuyukiTakata{TAKATAKAZUYUKI}____PatrycjaPabis{PABISPATRYCJA}|MartaChavero{CHAVEROMARTA}|TimoMyohanen{MYOHANENTIMO}|MasayaFujitani{FUJITANIMASAYA}|RyujiKato{KATORYUJI}|ScottDSmid{SMIDSCOTTD}|ABSmit{SMITAB}|MaartenLoos{LOOSMAARTEN}|BenjaminDrukarch{DRUKARCHBENJAMIN}|ShoheiKawanishi{KAWANISHISHOHEI}|ErikoKuroda{KURODAERIKO}|ShigehikoTakegami{TAKEGAMISHIGEHIKO}|TatsuyaKitade{KITADETATSUYA}|YukiToda{TODAYUKI}|YoshihisaKitamura{KITAMURAYOSHIHISA}|ShunShimohama{SHIMOHAMASHUN}|EishiAshihara{ASHIHARAEISHI}|ViolinaKakoty{KAKOTYVIOLINA}|RohitGoyal{GOYALROHIT}

O4

Oral session 4
Neuroscience 1: Dementia

14:50

LinLi{LILIN}|ZaijunZhang{ZHANGZAIJUN}|RishiPal{PALRISHI}|KohjiFukunaga{FUKUNAGAKOHJI}|-____Oral session 5
Neuroscience 2: Parkinsonism|1|1|LinLi{LILIN}|KohjiFukunaga{FUKUNAGAKOHJI}____LanZhang{ZHANGLAN}|Ru-YiZhang{ZHANGRU-YI}|BaojianGuo{GUOBAOJIAN}|ChengyouZheng{ZHENGCHENGYOU}|YuqiangWang{WANGYUQIANG}|ShipraKartik{KARTIKSHIPRA}|PrafullaCTiwari{TIWARIPRAFULLAC}|MayankJain{JAINMAYANK}|RajendraNath{NATHRAJENDRA}|KamleshKPant{PANTKAMLESHK}|YasushiYabuki{YABUKIYASUSHI}|KazuyaMatsuo{MATSUOKAZUYA}|HisanaoIzumi{IZUMIHISANAO}|YasuharuShinoda{SHINODAYASUHARU}

O5

Oral session 5
Neuroscience 2: Parkins...

08:30

-____JSCPT Session (Japanese)|1|1|-____

TABLE003

JSCPT Session (Japanese)

09:25

-____JSCPT Session (Japanese)|1|1|-____

TABLE004

JSCPT Session (Japanese)

15:00

-____JSCPT Session (Japanese)|1|1|-____

TABLE009

JSCPT Session (Japanese)

16:10

-____JSCPT Session (Japanese)|1|1|-____

TABLE010

JSCPT Session (Japanese)

14:00

-____JSCPT Session (Japanese)|1|1|-____

TABLE044

JSCPT Session (Japanese)

18:10

-____IUPHAR Clinical Pharmacology Division General Assembly|1|1|-____

TABLE049

IUPHAR Clinical Pharmacology Division General Assembly

Advanced Search